LifeStyle Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid… Taner Halicioglu Jul 12, 2023 DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable… Read More...
LifeStyle Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid… Taner Halicioglu Jul 12, 2023 DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable… Read More...
Health Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid… James Pereira Jul 12, 2023 DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable… Read More...
Health Global Nerve Repair and Regeneration Market is expected to grow at a lucrative rate of ~12% by 2027… James Pereira Apr 26, 2023 <!-- Name:DistributionId Value:1000806362 --> <!--… Read More...
Health Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the… James Pereira Oct 25, 2022 Phase II sham-controlled randomized trial met its primary endpoint with statistical significance; treatment slowed… Read More...
Health Sinaptica Therapeutics Announces FDA Breakthrough Device Designation for its Novel Noninvasive… James Pereira Oct 19, 2022 SinaptiStim™ – AD System provides personalized and precision-delivered electromagnetic therapeutic approach to treating… Read More...
Health Neurostimulation Devices Market Size is projected to reach USD 14 billion by 2030, growing at a CAGR… James Pereira Jul 11, 2022 New York, United States, July 11, 2022 (GLOBE NEWSWIRE) -- Neurostimulation devices assist patients suffering from… Read More...
Health Neurotech Devices Market worth USD 35.5 billion by 2030, Says Global Market Insights Inc. James Pereira May 25, 2022 Selbyville, Delaware, May 25, 2022 (GLOBE NEWSWIRE) -- The neurotech devices market value is expected to reach USD… Read More...
Health PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the… James Pereira Mar 7, 2022 BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial… Read More...
Health Adult epilepsy treatment reduces seizures in children: Seizures were reduced in children as young as… James Pereira Jan 6, 2022 A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children,… Read More...